C5a receptor (CD88) inhibition improves hypothermia-induced neuroprotection in an in vitro ischemic model

NeuroMolecular Medicine

Volumn 14, Issue 1, 2012, Pages 30-39

  Thundyil, John ^a   Pavlovski, Dale ^a   Hsieh, Yu Hsuan ^a   Gelderblom, Mathias ^b   Magnus, Tim ^b   Fairlie, David P ^a   Arumugam, Thiruma V ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Apoptosis; C5a receptor; Hypothermia; Neuronal cells; Neuroprotection

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL PROTECTION; CELL VIABILITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INDUCED HYPOTHERMIA; MOUSE; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NEWBORN; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHERMIA, INDUCED; MICE; MICE, INBRED C57BL; NEURONS; RECEPTOR, ANAPHYLATOXIN C5A; STROKE; TREATMENT OUTCOME;

EID: 84857994641     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-012-8167-0     Document Type: Article

References (40)

1. Albers, G. W., Goldstein, L. B., Hess, D. C., Wechsler, L. R., Furie, K. L., Gorelick, P. B., et al. (2011). Stroke treatment academic industry roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke, 42(9), 2645-2650.
2. Arumugam, T. V., Phillips, T. M., Cheng, A., Morrell, C. H., Mattson, M. P., & Wan, R. (2010). Age and energy intake interact to modify cell stress pathways and stroke outcome. Annals of Neurology, 67(1), 41-52.
3. Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Granger, D. N., &Taylor, S. M. (2004). The role of the complement system in ischemia-reperfusion injury. Shock, 21(5), 401-409.
4. Arumugam, T. V., Tang, S. C., Lathia, J. D., Cheng, A., Mughal, M. R., Chigurupati, S., et al. (2007). Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proceedings of the National Academy of Science USA, 104(35), 14104-14109. (Pubitemid 350003342)
5. Arumugam, T. V., Woodruff, T. M., Lathia, J. D., Selvaraj, P. K., Mattson, M. P., & Taylor, S. M. (2009). Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience, 158(3), 1074-1089.
6. Barone, F. C., Feuerstein, G. Z., & White, R. F. (1997). Brain cooling during transient focal ischemia provides complete neuroprotection. Neuroscience and Biobehavioral Reviews, 21(1), 31-44. (Pubitemid 27044548)
7. Bernard, S. (2006). Therapeutic hypothermia after cardiac arrest: Now a standard of care. Critical Care Medicine, 34(3), 923-924.
8. Bruno, V. M., Goldberg, M. P., Dugan, L. L., Giffard, R. G., & Choi, D. W. (1994). Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen-glucose deprivation or excitatory amino acids. Journal of Neurochemistry, 63(4), 1398-1406. (Pubitemid 24299526)
9. Busto, R., Globus, M. Y., Dietrich, W. D., Martinez, E., Valdes, I., &Ginsberg, M. D. (1989). Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke, 20(7), 904-910.
10. Den Hertog, H., van der Worp, B., van Gemert, M., & Dippel, D. (2007). Therapeutic hypothermia in acute ischemic stroke. Expert Review of Neurotherapeutics, 7(2), 155-164. (Pubitemid 46434165)
11. Finch, A. M., Wong, A. K., Wadi, S. K., Paczkowski, N. J., Fairlie, D. P., & Taylor, S. M. (1999). Low molecular weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. Journal of Medicinal Chemistry, 42, 1965-1974. (Pubitemid 29269629)
12. Froehler, M. T., & Ovbiagele, B. (2010). Therapeutic hypothermia for acute ischemic stroke. Expert Review of Cardiovascular Therapy, 8(4), 593-603.
13. Fujita, H., Tanaka, J., Toku, K., Tateishi, N., Suzuki, Y., Matsuda, S., et al. (1996). Effects of GM-CSF and ordinary supplements on the ramification of microglia in culture: A morphometrical study. Glia, 18(4), 269-281. (Pubitemid 27028293)
14. Ginsberg, M. D., Sternau, L. L., Globus, M. Y., Dietrich, W. D., &Busto, R. (1992). Therapeutic modulation of brain temperature: Relevance to ischemic brain injury. Cerebrovascular and Brain Metabolism Reviews, 4(3), 189-225.
15. Gladstone, D. J., Black, S. E., & Hakim, A. M. (2002). Toward wisdom from failure: Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke, 33(8), 2123-2136. (Pubitemid 34840080)
16. Globus, M. Y., Busto, R., Dietrich, W. D., Martinez, E., Valdes, I., &Ginsberg, M. D. (1988). Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia. Neuroscience Letters, 91(1), 36-40.
17. Lo, E. H., & Steinberg, G. K. (1992). Effects of hypothermia on evoked potentials, magnetic resonance imaging, and blood flow in focal ischemia in rabbits. Stroke, 23(6), 889-893.
18. LoPresti, P., Poluha, W., Poluha, D. K., Drinkwater, E., & Ross, A. H. (1992). Neuronal differentiation triggered by blocking cell proliferation. Cell Growth and Differentiation, 3(9), 627-635.
19. Maier, C. M., Sun, G. H., Kunis, D., Yenari, M. A., & Steinberg, G. K. (2001). Delayed induction and long-term effects of mild hypothermia in a focal model of transient cerebral ischemia: Neurological outcome and infarct size. Journal of Neurosurgery, 94(1), 90-96. (Pubitemid 32799477)
20. Manev, H., Cagnoli, C. M., Atabay, C., Kharlamov, E., Ikonomović, M. D., & Grayson, D. R. (1995). Neuronal apoptosis in an in vitro model of photochemically induced oxidative stress. Experimental Neurology, 133(2), 198-206.
21. Manzanero, S., Gelderblom, M., Magnus, T., & Arumugam, T. V. (2011). Calorie restriction and stroke. Experimental & Translational Stroke Medicine, 12(3), 8.
22. Mattson, M. P., Duan, W., Pedersen, W. A., & Culmsee, C. (2001). Neurodegenerative disorders and ischemic brain diseases. Apoptosis, 6(1-2), 69-81. (Pubitemid 32233956)
23. Mergenthaler, P., Dirnagl, U., & Meisel, A. (2004). Pathophysiology of stroke: Lessons from animal models. Metabolic Brain Disease, 19(3-4), 151-167. (Pubitemid 39361178)
24. Monk, P. N., Scola, A.-M., Madala, P. K., & Fairlie, D. P. (2007). Function, structure and therapeutic potential of complement C5a receptors. British Journal of Pharmacology, 152, 429-448. (Pubitemid 47585036)
25. O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006). 1,026 experimental treatments in acute stroke. Annals of Neurology, 59(3), 467-477. (Pubitemid 43358067)
26. Okun, E., Griffioen, K. J., Lathia, J. D., Tang, S. C., Mattson, M. P., &Arumugam, T. V. (2009). Toll-like receptors in neurodegeneration. Brain Research Reviews, 59(2), 278-292.
27. Reid, R. C., Abbenante, G., Taylor, S. M., & Fairlie, D. P. (2003). A convergent solution phase synthesis of the macrocycle, Ac-Phe-[Orn-Pro-D-Cha- Trp-Arg], a potent new anti-inflammatory drug. Journal of Organic Chemistry, 68, 4464-4471. (Pubitemid 36622736)
28. Saver, J. L., Albers, G. W., Dunn, B., Johnston, K. C., & Fisher, M. (2009). Stroke therapy academic industry roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke, 40(7), 2594-2600.
29. Scola, A. M., Higginbottom, A., Partridge, L. J., Reid, R. C., Woodruff, T., Taylor, S. M., et al. (2007). The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. Journal of Biological Chemistry, 282(6), 3664-3671. (Pubitemid 47084475)
30. Tang, S. C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., et al. (2007). Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits. Proceedings of the National Academy of Science USA, 104(34), 13798-13803. (Pubitemid 350003400)
31. Thundyil, J., Tang, S. C., Okun, E., Shah, K., Karamyan, V. T., Li, Y. I., et al. (2010). Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Experimental & Translational Stroke Medicine, 2(1), 15.
32. Van Beek, J., Bernaudin, M., Petit, E., Gasque, P., Nouvelot, A., MacKenzie, E. T., et al. (2000). Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Experimental Neurology, 161(1), 373-382. (Pubitemid 30136558)
33. Van der Worp, H. B., Sena, E. S., Donnan, G. A., Howells, D. W., &Macleod, M. R. (2007). Hypothermia in animal models of acute ischaemic stroke: A systematic review and meta-analysis. Brain, 130(Pt 12), 3063-3074. (Pubitemid 350209058)
34. Van Lith, L. H., Oosterom, J., Van Elsas, A., & Zaman, G. J. (2009). C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. Journal of Biomolecular Screening, 14(9), 1067-1075.
35. Varathan, S., Shibuta, S., Shimizu, T., & Mashimo, T. (2001). Neuroprotective effect of hypothermia at defined intraischemic time courses in cortical cultures. Journal of Neuroscience Research, 65(6), 583-590. (Pubitemid 32847151)
36. Veerhuis, R., Nielsen, H. M., & Tenner, A. J. (2011). Complement in the brain. Molecular Immunology, 48(14), 1592-1603.
37. Wong, A. K., Finch, A. M., Pierens, G. K., Craik, D. J., Taylor, S. M., & Fairlie, D. P. (1998). Small molecular probes for G-protein-coupled C5a receptors: Conformationally constrained antagonists derived from the C-terminus of the human plasma protein C5a. Journal of Medicinal Chemistry, 41, 3417-3425. (Pubitemid 28406549)
38. Woodruff, T. M., Thundyil, J., Tang, S. C., Sobey, C. G., Taylor, S. M., & Arumugam, T. V. (2011). Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Molecular Neurodegeneration, 6(1), 11.
39. Xu, L., Yenari, M. A., Steinberg, G. K., & Giffard, R. G. (2002). Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. Journal of Cerebral Blood Flow and Metabolism, 22(1), 21-28. (Pubitemid 34038379)
40. Yang, L., Tanaka, J., Zhang, B., Sakanaka, M., & Maeda, N. (1998). Astrocytes modulate nitric oxide production by microglial cells through secretion of serine and glycine. Biochemical and Biophysical Research Communications, 251(1), 277-282. (Pubitemid 28498102)